1. Home
  2. DWSN vs RANI Comparison

DWSN vs RANI Comparison

Compare DWSN & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DWSN

Dawson Geophysical Company

SELL

Current Price

$4.98

Market Cap

130.4M

Sector

Energy

ML Signal

SELL

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$0.85

Market Cap

106.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DWSN
RANI
Founded
1952
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medicinal Chemicals and Botanical Products
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
130.4M
106.9M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
DWSN
RANI
Price
$4.98
$0.85
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.50
AVG Volume (30 Days)
312.9K
995.2K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
53.85
57.14
EPS
0.25
N/A
Revenue
$145,773,000.00
$1,633,000.00
Revenue This Year
N/A
$274.77
Revenue Next Year
N/A
$79.44
P/E Ratio
$19.04
N/A
Revenue Growth
N/A
58.85
52 Week Low
$1.27
$0.44
52 Week High
$7.85
$3.87

Technical Indicators

Market Signals
Indicator
DWSN
RANI
Relative Strength Index (RSI) 48.80 60.55
Support Level $3.66 $0.69
Resistance Level $4.93 $1.05
Average True Range (ATR) 0.73 0.08
MACD -0.14 0.03
Stochastic Oscillator 26.48 72.90

Price Performance

Historical Comparison
DWSN
RANI

About DWSN Dawson Geophysical Company

Dawson Geophysical Co provides seismic data acquisition services mainly to providers of multi-client data libraries and directly to onshore oil and natural gas exploration and development companies in the continental U.S. and Canada. The demand for seismic services is largely influenced by drilling and completion activity, exploration budgets, and prevailing and anticipated crude oil and natural gas prices. Its data acquisition crews serve companies engaged in the exploration and development of oil and gas on land and in land-to-water transition areas. The business operates through two reportable segments, with U.S. operations generating the majority of revenue and Canada operations contributing additionally.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: